AGP Executive Report
Last update: 7 hours agoMedical Device & Regulatory News: Implantica’s RefluxStop® reports strong Q2 momentum, with sales up 66% to TEUR 717 and a large multi-center safety study in Nature’s Scientific Reports covering 602 patients; the big headline is FDA PMA approval, paving the way for a U.S. launch. Transplant Care: Hansa Biopharma says Australia’s first commercial patient received a living-donor kidney transplant using Idefirix (imlifidase) for highly sensitised candidates, aiming to improve access when antibodies block compatibility. Royal Health Update: Norway’s King Harald V was admitted to hospital for fluid retention linked to cortisone treatment for hemolytic anaemia, with the Crown Prince acting as regent during a two-week sick leave. Public Health & Data Privacy: France’s tax authority breach involved highly specific withholding and income details for about 678,000 people, raising the risk of convincing impersonation scams as notifications go out. Border Health Tech (Travel): The EU Entry/Exit System (EES) is fully operational, using digital records and biometrics for non-EU short stays—changing what travelers experience at Schengen borders. Health Policy Context: EU sanctions alignment expands to include Liechtenstein among eight non-EU countries backing Belarus measures, with knock-on effects for cross-border compliance.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
